{
    "Trade/Device Name(s)": [
        "Abbott ARCHITECT Free T4"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "k123379",
    "Predicate Device Reference 510(k) Number(s)": [
        "k983417"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "November 27, 2012",
    "Summary Letter Received Date": "November 1, 2012",
    "Submission Date": "October 30, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1695"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free thyroxine (Free T4)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott ARCHITECT Free T4 assay modification from 2-point to 6-point calibration for quantitative measurement of free thyroxine in serum and plasma",
    "Indications for Use Summary": "Quantitative determination of free thyroxine in human serum and plasma as an aid in the assessment of thyroid status, including calibrators and controls for ARCHITECT i System",
    "fda_folder": "Clinical Chemistry"
}